4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-065943
Options or other derivatives
- Chief Medical Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/ownership.xml…